Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Lemaitre Vascular (LMAT) over the last 16 years, with Q3 2025 value amounting to -$27.4 million.

  • Lemaitre Vascular's Cash from Investing Activities fell 11336.29% to -$27.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$222.0 million, marking a year-over-year decrease of 67927.62%. This contributed to the annual value of -$200.1 million for FY2024, which is 70971.07% down from last year.
  • Latest data reveals that Lemaitre Vascular reported Cash from Investing Activities of -$27.4 million as of Q3 2025, which was down 11336.29% from -$16.3 million recorded in Q2 2025.
  • Over the past 5 years, Lemaitre Vascular's Cash from Investing Activities peaked at -$402000.0 during Q4 2022, and registered a low of -$173.9 million during Q4 2024.
  • Moreover, its 5-year median value for Cash from Investing Activities was -$7.2 million (2021), whereas its average is -$18.1 million.
  • As far as peak fluctuations go, Lemaitre Vascular's Cash from Investing Activities skyrocketed by 9757.8% in 2021, and later crashed by 759093.32% in 2024.
  • Lemaitre Vascular's Cash from Investing Activities (Quarter) stood at -$7.2 million in 2021, then surged by 94.45% to -$402000.0 in 2022, then plummeted by 462.44% to -$2.3 million in 2023, then tumbled by 7590.93% to -$173.9 million in 2024, then skyrocketed by 84.22% to -$27.4 million in 2025.
  • Its Cash from Investing Activities stands at -$27.4 million for Q3 2025, versus -$16.3 million for Q2 2025 and -$4.3 million for Q1 2025.